CYCC - Daily - Steer clearCyclacel Pharmaceuticals, Inc.BATS:CYCCRoninAITraderIf a company is being forced to split just to stay in line with exchange regulations, that's a huge warning sign right there—it's a clear indication to avoid investing. Secondly, consider this: a company that's been around since 1996 and still can't crack a $50 million market cap? That screams problems with their leadership. Financially, while there was a notable bump in net income between 2023 and 2024, it's not nearly enough to suggest they'll be consistently profitable, especially when you look back at how they were basically hemorrhaging cash from 2020 to 2023. And here's another kicker: despite some improvement in free cash flow since 2022, their cash and equivalents are almost entirely gone. This suggests they might just be shifting expenses around, which is never a good sign. Finally, while it might look like it's targeting the 100 moving average, you've got to ask yourself if you're truly willing to take the hit if it doesn't go your way. If the answer is no, then you're already on your way to being a smarter trader. Move on, there's absolutely nothing special happening here. Not financial advice, always do your due diligence Leave a like👍 and/or comment💬. We appreciate and value everyone's feedback! - RoninAITrader